| IVF-PE group (n = 117) | NC-PE group (n = 64) | P value |
---|---|---|---|
Gestational age at delivery (weeks) | 35.27 ± 2.05 | 35.21 ± 2.24 | 0.853 |
Gestational age at diagnosis (weeks) | 32.68 ± 2.64 | 33.76 ± 2.58 | 0.009 |
Hospitalization time (days) | 9.44 ± 5.57 | 8.94 ± 3.71 | 0.474 |
Maximum systolic BP, mmHg | 163.17 ± 12.06 | 163.63 ± 10.24 | 0.799 |
Maximum diastolic BP, mmHg | 102.99 ± 7.74 | 101.64 ± 6.69 | 0.241 |
Systolic BP ≥ 180 mmHg n (%) | 12 (10.2) | 6 (9.4) | 0.850 |
Diastolic BP ≥ 120 mmHg n (%) | 3 (2.6) | 0 (0) | 0.495 |
24-hour urine protein (g) | 2.53 ± 3.40 | 2.09 ± 2.44 | 0.354 |
Severe PE n (%) | 97 (82.9) | 48 (75.0) | 0.203 |
Early-onset PE n (%) | 92 (78.6) | 28 (43.8) | < 0.001 |
Pleural effusion and (or) ascites n (%) | 22 (18.8) | 10 (15.6) | 0.592 |
Liver or (and) renal insufficiency n (%) | 14 (12.0) | 8 (12.5) | 0.916 |
Thrombocytopenia n (%) | 10 (8.5) | 4 (6.3) | 0.793 |
Placental abruption n (%) | 10 (8.5) | 2 (3.1) | 0.276 |
HELLP syndrome n (%) | 8 (6.8) | 2 (3.1) | 0.481 |
Eclampsia or Cardiac failure n (%) | 5 (4.3) | 3 (4.7) | 1.000 |
Maternal complications | |||
 Gestational diabetes mellitus n (%) | 28 (23.9) | 14 (21.9) | 0.754 |
 Ggestationa hypothyroidism n (%) | 13 (11.1) | 6 (9.4) | 0.716 |
 Intrahepatic cholestasis during pregnancy n (%) | 13 (11.1) | 7 (10.9) | 0.972 |
 Postpartum hemorrhage n (%) | 20 (17.1) | 6 (9.4) | 0.157 |
 Oligohydramnios n (%) | 5 (4.3) | 4 (6.3) | 0.820 |
 Growth discordance in twins n (%) | 13 (11.1) | 16 (25.0) | 0.015 |
 Intrauterine growth retardation n (%) | 35 (29.9) | 24 (37.5) | 0.298 |
Perinatal outcome | |||
 Birth weight (g) | 2266.26 ± 498.66 | 2212.97 ± 499.93 | 0.493 |
 Caesarean section n (%) | 113 (96.6) | 60 (93.8) | 0.612 |
 Preterm delivery n (%) | 64 (54.7) | 35 (54.7) | 0.999 |
 Very preterm delivery(< 34 weeks) n (%) | 25 (21.4) | 14 (21.9) | 0.937 |
 Very low birth weight n (%) | 11 (9.4) | 8 (12.5) | 0.516 |
 Neonatal asphyxia n (%) | 64 (54.7) | 38 (59.4) | 0.544 |